[VRTX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
06-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 11.38%
YoY- -126.02%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 310,750 328,368 333,994 336,006 418,305 438,737 563,340 -32.76%
PBT -63,511 -442,940 -80,772 -5,112 -14,405 87,908 210,801 -
Tax -1,799 -130,313 -2,696 21,355 20,063 32 22,660 -
NP -57,165 -308,016 -76,148 -57,543 -64,931 91,590 158,629 -
Tax Rate - - - - - -0.04% -10.75% -
Total Cost 367,915 636,384 410,142 393,549 483,236 347,147 404,711 -6.16%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -18.40 -93.80 -22.80 -17.13 -15.52 20.88 28.16 -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -0.26 -1.43 -0.35 -0.27 -0.31 0.44 0.76 -
EPS Diluted -0.26 -1.43 -0.35 -0.27 -0.31 0.43 0.72 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.